In addition, Chakraborty et al. reported that the TLR4/NLR signaling pathway promotes ineffective hematopoiesis through the activation of damage-associated molecular patterns, which contribute to the development of AML [48]. The gene discussed is TLR4; the disease is acute myeloid leukemia.